Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jaguar Health (JAGX) FCF Margin (2016 - 2025)

Jaguar Health (JAGX) has disclosed FCF Margin for 11 consecutive years, with 152.09% as the latest value for Q3 2025.

  • On a quarterly basis, FCF Margin rose 5193.0% to 152.09% in Q3 2025 year-over-year; TTM through Sep 2025 was 220.82%, a 14905.0% increase, with the full-year FY2024 number at 251.52%, up 8904.0% from a year prior.
  • FCF Margin was 152.09% for Q3 2025 at Jaguar Health, up from 207.89% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 152.09% in Q3 2025 to a low of 165116.67% in Q2 2021.
  • A 5-year average of 10523.72% and a median of 323.96% in 2023 define the central range for FCF Margin.
  • Peak YoY movement for FCF Margin: tumbled -16499030bps in 2021, then surged 16475867bps in 2022.
  • Jaguar Health's FCF Margin stood at 428.99% in 2021, then soared by 54bps to 196.0% in 2022, then crashed by -65bps to 323.96% in 2023, then surged by 31bps to 223.03% in 2024, then skyrocketed by 32bps to 152.09% in 2025.
  • Per Business Quant, the three most recent readings for JAGX's FCF Margin are 152.09% (Q3 2025), 207.89% (Q2 2025), and 330.44% (Q1 2025).